Octagon Therapeutics
octagontherapeutics.comOctagon Therapeutics is listed in the VCMatch investor directory. Upload your deck to compare your startup against VCMatch's private fit signals for this investor.
Check Size
Not specified
Stages
Not specified
Focus Areas
Not specified
Geography
Not specified
Investment Thesis
Octagon Therapeutics is focused on discovering and developing medicines for patients with autoimmune and inflammatory diseases by leveraging proprietary insights into the glycoproteome. The company believes that patients with severe autoimmunity deserve treatment options that preserve healthy immune functioning, rather than broadly suppressing the immune system. Their approach centers on restoring the activity of disrupted immune checkpoint receptors to restore healthy immune homeostasis.
Is Octagon Therapeutics right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
Octagon Therapeutics is most relevant for founders raising venture-backed rounds in their stated focus areas.
Focus statement
Octagon targets autoimmune and inflammatory diseases including systemic lupus erythematosus, multiple sclerosis, Sjögren's, myositis, and metabolic/inflammatory conditions. They utilize a proprietary glycoproteome discovery platform to identify disease-driving biology and develop selective immune checkpoint modulators.
Value Add
- Proprietary Glycoproteome Discovery Engine that leverages glycobiology insights - glycans increase proteome diversity by orders of magnitude and affect protein receptor binding, enzymatic processing, and stability
- Focus on selective immune checkpoint restoration rather than broad immunosuppression, specifically targeting autoimmune checkpoints while preserving healthy immune function
- Ability to target disease-associated lymphocytes with high specificity - evidenced by partnership with Novo Nordisk for inflammatory disease targets
- Scientific foundation from Harvard with experienced team of scientists, clinicians, and entrepreneurs with decades of research experience
- Established partnerships with leading institutions including Slater Technology Fund, Novo Nordisk, and presence at The Engine in Cambridge
Ready to find your perfect investor match?
Get Started Free